EFFECTS OF COMBINATION THERAPY WITH DUTASTERIDE AND TAMSULOSIN ON CLINICAL OUTCOMES IN MEN WITH SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA FOUR YEAR RESULTS FROM THE COMBAT STUDY

被引：0

作者：

Roehrborn, C. G. ^{[1
]}

Barkin, J. ^{[2
]}

Siami, P. ^{[3
]}

Tubaro, A. ^{[4
]}

Damiao, R. ^{[5
]}

Gagnier, R. P. ^{[6
]}

Castro, R. ^{[6
]}

Morrill, B. ^{[6
]}

Nandy, I. ^{[6
]}

Montorsi, F. ^{[7
]}

机构：

[1] UT SW Med Ctr, Dept Urol, Dallas, TX USA

[2] Univ Toronto, Dept Urol, Toronto, ON, Canada

[3] Welborn Clin, Evansville, IN USA

[4] Univ Rome, St Andrea Hosp, Rome, Italy

[5] Hosp Univ Pedro Ernesto UERJ, Serv Urol, Rio De Janeiro, Brazil

[6] GlaxoSmithKline Inc, Res & Dev, Res Triangle Pk, NC USA

[7] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy

来源：

JOURNAL OF MENS HEALTH | 2009年 / 6卷 / 03期

关键词：

D O I：

10.1016/j.jomh.2009.08.162

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

165

引用

页码：268 / 268

页数：1

共 50 条

[21] Fixed-dose combination therapy with dutasteride and tamsulosin in the management of benign prostatic hyperplasia
Dimitropoulos, Konstantinos
Gravas, Stavros
[J]. THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (01) : 19 - 28
[22] Combination therapy with dutasteride and tarnsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement:: the CombAT (Combination of Avodart® and Tamsulosin) trial rationale and study design
Siami, Paul
Roehrborn, Claus G.
Barkin, Jack
Damiao, Ronaldo
Wyczolkowski, Marek
Duggan, Annette
Major-Walker, Kim
Morrill, Betsy B.
[J]. CONTEMPORARY CLINICAL TRIALS, 2007, 28 (06) : 770 - 779
[23] THE EFFECTS OF DUTASTERIDE OR TAMSULOSIN ALONE AND IN COMBINATION ON STORAGE AND VOIDING SYMPTOMS IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) AND BENIGN PROSTATIC HYPERPLASIA (BPH): 4-YEAR DATA FROM THE COMBINATION OF AVODART AND TAMSULOSIN (CombAT) STUDY
Woo, Henry
[J]. BJU INTERNATIONAL, 2011, 107 (09) : 1431 - 1431
[24] Re: Clinical Outcomes After Combined Therapy With Dutasteride Plus Tamsulosin or Either Monotherapy in Men With Benign Prostatic Hyperplasia (BPH) by Baseline Characteristics: 4-Year Results From the Randomized, Double-Blind Combination of Avodart and Tamsulosin (CombAT) Trial Editorial Comment
Kaplan, Steven A.
[J]. JOURNAL OF UROLOGY, 2012, 187 (02): : 583 - 584
[25] The effect of tamsulosin and dutasteride combination drug therapy on prostate volume in patients with benign prostatic hyperplasia
Nandana, P., I
Adipura, L. R.
Rasyid, H.
[J]. 3RD INTERNATIONAL CONFERENCE ON BIOSCIENCE AND BIOTECHNOLOGY, 2021, 712
[26] COST-EFFECTIVENESS ANALYSIS OF DUTASTERIDE, TAMSULOSIN AND COMBINATION THERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Bang, S., I
Hay, J.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A78 - A78
[27] Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: Long-term results from the combination of dutasteride and tamsulosin study
Chung, Byung-Ha
Lee, Seung Hwan
Roehrborn, Claus G.
Siami, Paul F.
Major-Walker, Kim
Wilson, Timothy H.
Montorsi, Francesco
[J]. INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (11) : 1031 - 1035
[28] COMBINATION THERAPY OF TADALAFIL AND TAMSULOSIN FOR MEN WITH MODERATE TO SEVERE BENIGN PROSTATIC HYPERPLASIA
Park, Hyun Jun
Kim, Tae Nam
Nam, Jong Kil
Moon, Du Geon
Park, Nam Cheol
[J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E100 - E100
[29] Clinical study of combination therapy of tamsulosin and solifenacin for benign prostatic hyperplasia with overactive bladder
蒋晨
[J]. 外科研究与新技术, 2011, 20 (04) : 256 - 257
[30] Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia
Roehrborn, CG
Marks, LS
Fenter, T
Freedman, S
Tuttle, J
Gittleman, M
Morrill, B
Wolford, ET
[J]. UROLOGY, 2004, 63 (04) : 709 - 715

← 1 2 3 4 5 →